Optinose Named a 2018 Best Place to Work by Philadelphia

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
51
Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal

YARDLEY, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has been named one of the  Philadelphia Business Journal ’s “Best Places to Work” for 2018 in the medium-sized company category.

“We are proud of every single person on the Optinose team for creating a Philadelphia Business Journal ‘Best Place to Work,’ because we know that our company’s wonderful culture is a result of the ownership that is felt by every colleague,” said Peter Miller, CEO of Optinose. “Building a company where people love to come to work has been a priority for us ever since we started Optinose.”

“Recognition as a ‘Best Place to Work’ means our team is succeeding in creating the shared culture we all aspire to, one that is based on core values,” added Ramy Mahmoud, President and Chief Operating Officer of Optinose. “Even with our rapid growth, our colleagues are successfully sustaining core values such as Friendship, Authenticity, Openness, Possibility Thinking, and of course ‘One Mission.’ These shared values are reflected in how we work every day and we believe they have been essential to our track record of success in both developing and commercializing innovative new products.”

Over the past year, Optinose has grown from 22 to more than 90 colleagues globally, with over 60 based in the headquarters in Yardley. It has also achieved a second FDA product approval, launched an important new product (XHANCE TM ), and completed a successful IPO.  More information about the shared purpose that unites the people of Optinose is here , and more information about career opportunities is here .

The Philadelphia Business Journal names companies to its “Best Places to Work” list using a rigorous scientific process based on responses to an independent employee engagement survey conducted by Quantum Workplace. As a finalist, Optinose’s culture was favorably ranked by employees in areas including work environment, people, personal growth, and professional development. 

About Optinose Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn .

Optinose Investor Contact Jonathan Neely jonathan.neely@optinose.com   267.521.0531

Optinose Media Contact Kate Traynor, Sloane & Company ktraynor@sloanepr.com   212.446.1871

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 8

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 2

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

QuEra's New Fault Tolerance Breakthrough for Quantum Computing

Updated Category News Views 419

Revolutionizing Quantum Computing with Fault Tolerance QuEra Computing has made significant strides in the realm of quantum technology with their newly introduced framework aimed at enhancing algorithmic fault tolerance. This revolutionary approach, published in a leading journal, promises to drastically reduce the time overhead involved in error correction for quantum...

Continue Reading
Assembly Biosciences Provides Update on 2024 Financial Performance

Updated Category News Views 140

Assembly Biosciences' Recent Financial Overview Assembly Biosciences, Inc. (Nasdaq: ASMB), a prominent name in biotechnology, is focused on developing promising therapies for viral diseases. The company recently shared its financial results for the year ending December 31, 2024, highlighting key developments in its antiviral pipeline. Their progress continues to generate...

Continue Reading
Empowering Seniors: Property Tax Relief Initiatives Explained

Updated Category News Views 266

Understanding Property Tax Deferral for Seniors With the rising cost of living, many seniors are feeling the strain of increasing property taxes. To address this, Cook County Treasurer María Pappas advocates for the Senior Citizens Property Tax Deferral Program. This state initiative is designed specifically for homeowners aged 65 and older, offering a pathway to...

Continue Reading
Understanding Investor Sentiment Towards Electronic Arts Inc.

Updated Category News Views 228

Understanding Investor Sentiment Towards Electronic Arts Inc. Electronic Arts Inc (NYSE: EA) has witnessed a notable decrease in short interest relative to its available shares. The current data reveals that there are approximately 4.08 million shares sold short, representing about 1.86% of the total shares available for trading. With the average trading volume observed,...

Continue Reading
Innovative Partnership to Advance AI with Next-Gen Chiplet Tech

Updated Category News Views 382

Introducing a Game-Changing Partnership in AI Technology DreamBig Semiconductor has recently made waves in the tech industry by joining forces with Samsung Foundry. This collaboration aims to roll out advanced chiplets designed specifically for the innovative MARS Chiplet Platform. Utilizing the cutting-edge 4nm FinFET process technology, these chiplets promise to address...

Continue Reading